enerisant (TS-091) / Taisho  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
enerisant (TS-091) / Taisho
NCT03267303: A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy

Completed
2
53
Japan, RoW
TS-091 5mg, TS-091 10mg, Placebo
Taisho Pharmaceutical Co., Ltd.
Narcolepsy
12/18
08/19

Download Options